Detalhe da pesquisa
1.
Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
J Transl Med
; 22(1): 42, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200511
2.
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy.
Arch Microbiol
; 205(10): 338, 2023 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742282
3.
Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
Eur J Nucl Med Mol Imaging
; 48(5): 1550-1559, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128571
4.
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.
Cancers (Basel)
; 16(2)2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254838
5.
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Oral Oncol
; 148: 106623, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006691
6.
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study.
Sci Rep
; 13(1): 11065, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422576
7.
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
JTO Clin Res Rep
; 4(12): 100602, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124790
8.
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Cancers (Basel)
; 15(15)2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568646
9.
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.
Cancer Treat Res Commun
; 37: 100767, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832364
10.
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Front Oncol
; 13: 1196414, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546399
11.
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota.
Cancer Discov
; 12(4): 1070-1087, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031549
12.
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study.
Thromb Res
; 205: 29-39, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246011
13.
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study.
Eur J Cancer
; 142: 83-91, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242835
14.
Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France.
J Geriatr Oncol
; 11(5): 802-806, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948904
15.
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
Eur J Cancer
; 139: 181-187, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035991
16.
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors.
Oncoimmunology
; 8(4): e1568812, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906663
17.
[Towards interprofessional collaboration]. / Vers la collaboration interprofessionnelle.
Perspect Infirm
; 1(6): 23-7, 2004.
Artigo
em Francês
| MEDLINE | ID: mdl-15984286